Inventor · disambiguated record
Jean-Pierre Gotteland
Also filed as: GOTTELAND JEAN-PIERRE
23 granted patents·21 pending applications·81 citations·filing 2000–2024
93Inventor score
Top patents by PatentIndex Score
44 records- 0186US7838522B2Benzothiazole formulations and use thereofARES TRADING SA·Filed 2005·Granted Nov 23, 2010·21 cites·22 claims
- 0286US7544700B2Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein JunKinasesSERONO LAB·Filed 2001·Granted Jun 9, 2009·29 cites·21 claims
- 0385US10555934B2Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereofObsEva SA·Filed 2017·Granted Feb 11, 2020·4 cites·60 claims
- 0482US8017628B2Pharmaceutically active sulfonyl hydrazide derivativesMERCK SERONO SA·Filed 2008·Granted Sep 13, 2011·5 cites·14 claims
- 0581US11759464B2Gonadotropin-releasing hormone antagonist dosing regimens for treating uterine fibroids and reducing menstrual blood lossObsEva SA·Filed 2018·Granted Sep 19, 2023·1 cites·15 claims
- 0678US7417058B2Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinasesSERONO LAB·Filed 2001·Granted Aug 26, 2008·11 cites·13 claims
- 0775US11980621B2Gonadotropin-releasing hormone antagonist dosing regimens for the treatment of endometriosisObsEva SA·Filed 2018·Granted May 14, 2024·1 cites·20 claims
- 0874US2023321052A1Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereofObsEva SA·Filed 2022·Application pending·0 cites
- 0972US2024000785A1Gonadotropin-releasing hormone antagonist dosing regimens for treating uterine fibroids and reducing menstrual blood lossKISSEI PHARMACEUTICAL·Filed 2023·Application pending·0 cites
- 1072US2024293414A1Gonadotropin-releasing hormone antagonist dosing regimens for the treatment of endometriosisKISSEI PHARMACEUTICAL·Filed 2024·Application pending·0 cites
- 1169US11534428B1Compositions and methods for delaying the incidence of laborObsEva SA·Filed 2019·Granted Dec 27, 2022·0 cites·11 claims
- 1269US11524003B2Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereofObsEva SA·Filed 2020·Granted Dec 13, 2022·0 cites·20 claims
- 1369US2023372306A1Compositions and methods for delaying the incidence of laborXOMA US LLC·Filed 2022·Application pending·0 cites
- 1468US7259162B2Benzazole derivatives and their use as JNK modulatorsAPPLIED RESEARCH SYSTEMS·Filed 2000·Granted Aug 21, 2007·3 cites·15 claims
- 1564US8012995B1Pharmaceutically active sulfonamide derivativesMERCK SERONO SA·Filed 2000·Granted Sep 6, 2011·2 cites·19 claims
- 1664US7683078B2Arylsulfonamide derivatives as C-Jun-N-Terminal Kinases (JNK's) inhibitorsSERONO LAB·Filed 2002·Granted Mar 23, 2010·2 cites·13 claims
- 1762US10441534B2Method for treating gynecological diseasesPREGLEM SA·Filed 2013·Granted Oct 15, 2019·1 cites·20 claims
- 1860US12280052B2Compositions and methods for the treatment of adenomyosis and rectovaginal endometriosisObsEva SA·Filed 2019·Granted Apr 22, 2025·0 cites·11 claims
- 1959US7314878B2Piperazine benzothiazoles as agents for the treatment of cerebral ischemic disorders or CNS disordersSERONO LAB·Filed 2003·Granted Jan 1, 2008·1 cites·9 claims
- 2059US2010029719A1Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitorsSERONO LAB·Filed 2009·Application pending·0 cites
- 2158US8008341B2Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinasesMERCK SERONO SA·Filed 2008·Granted Aug 30, 2011·0 cites·10 claims
- 2258US2024024294A1Compositions and methods for the treatment or prevention of preterm laborXOMA US LLC·Filed 2021·Application pending·0 cites
- 2355US7470686B2Method of inhibiting the expression and/or the activity of JNKSERONO LAB·Filed 2007·Granted Dec 30, 2008·0 cites·12 claims
- 2455US2023102503A1Biomarkers for oxytocin receptor antagonist therapyObsEva SA·Filed 2021·Application pending·0 cites
- 2551US2007088017A1Benzothiazole derivatives for the treatment of diabetesAPPLIED RESEARCH SYSTEMS·Filed 2004·Application pending·0 cites
- 2651US2014107116A1Benzothiazole derivatives for the treatment of diabetesMERCK SERONO SA·Filed 2013·Application pending·0 cites
- 2751US2011118224A1Use of steroid sulfatase inhibitors for the treatment of preterm laborPREGLEM SA·Filed 2009·Application pending·0 cites
- 2849US2022305017A1Compositions and methods for the treatment of estrogen-dependent disordersObsEva SA·Filed 2020·Application pending·0 cites
- 2949US2022288154A1Gnrh antagonists for the treatment of estrogen-dependent disordersObsEva SA·Filed 2020·Application pending·0 cites
- 3049US2022323410A1Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriageObsEva SA·Filed 2020·Application pending·0 cites
- 3147US2007185104A1Benzoxazole acetonitrilesAPPLIED RESEARCH SYSTEMS·Filed 2004·Application pending·0 cites
- 3246US7855212B2Pyridinyl acetonitrilesMERCK SERONO SA·Filed 2004·Granted Dec 21, 2010·0 cites·6 claims
- 3346US7705052B2Sulfonamide derivatives for the treatment of diabetesMERCK SERONO SA·Filed 2004·Granted Apr 27, 2010·0 cites·9 claims
- 3445US7432286B1Pharmaceutically active sulfonyl hydrazide derivativesSERONO LAB·Filed 2000·Granted Oct 7, 2008·0 cites·33 claims
- 3545US2023067378A1Compositions and methods for the treatment of estrogen-dependent disordersObsEva SA·Filed 2019·Application pending·0 cites
- 3644US2007203134A1Benzimidazole AcetonitrilesAPPLIED RESEARCH SYSTEMS·Filed 2004·Application pending·0 cites
- 3742US7776854B2Benzazole derivatives for the treatment of sclerodermaMERCK SERONO SA·Filed 2002·Granted Aug 17, 2010·0 cites·9 claims
- 3842US7465736B2Azole methylidene cyanide derivatives and their use as protein kinase modulatorsSERONO LAB·Filed 2003·Granted Dec 16, 2008·0 cites·18 claims
- 3940US2015065470A1Steroid Sulfatase Inhibitor Regimen for the Treatment of EndometriosisPREGLEM SA·Filed 2013·Application pending·0 cites
- 4040US2015209373A1Progesterone Receptor Modulators for Use in Preventing or Treating Androgen Mediated DiseasesPREGLEM SA·Filed 2013·Application pending·0 cites
- 4140US2004077632A1Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinasesFiled 2001·Application pending·0 cites
- 4240US2019247361A1Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriageObsEva SA·Filed 2017·Application pending·0 cites
- 4339US7638538B1Pharmaceutically active sulfonyl amino acid derivativesSERONO LAB·Filed 2000·Granted Dec 29, 2009·0 cites·4 claims
- 4439US2009176762A1JNK Inhibitors for Treatment of Skin DiseasesSERONO LAB·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jean-Pierre Gotteland files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →